Cantor Equity Partners II adds Dr. Prasad to board
Cantor Equity Partners II, Inc. appointed Dr. Mukesh Prasad to its board of directors as a Class II director, effective May 8, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Cantor Equity Partners II, Inc. appointed Dr. Mukesh Prasad to its board of directors as a Class II director, effective May 8, 2026. He was also named to the board’s audit and compensation committees.
Dr. Prasad, age 55, is Founder and Co-Managing Partner of Innova Capital Partners and an Otolaryngologist and Associate Professor at Weill Cornell Medical College. He will receive $50,000 per year, paid quarterly, for board service.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Effective appointment date: May 8, 2026
Director age: 55 years
Board compensation: $50,000 per year
+3 more
6 metrics
Effective appointment date
May 8, 2026
Date Dr. Mukesh Prasad joined the board as a Class II director
Director age
55 years
Age of Dr. Mukesh Prasad at time of appointment
Board compensation
$50,000 per year
Annual compensation for Dr. Prasad’s board service, paid quarterly
Innova leadership start
Since 2014
Dr. Prasad has served as Founder and Co-Managing Partner of Innova Capital Partners
Weill Cornell service
Since 2002
Dr. Prasad has practiced and served as Associate Professor at Weill Cornell Medical College
Council on Foreign Relations membership
Since 2015
Membership tenure for Dr. Prasad
Key Terms
Class II director, audit committee, compensation committee, Emerging growth company, +2 more
6 terms
Class II director financial
"Dr. Prasad will serve as a Class II director."
A class II director is a member of a company’s board who belongs to one of several staggered groups of directors, each group standing for election in different years. For investors, this matters because staggered terms slow wholesale board turnover—like rotating members of a neighborhood committee—making sudden changes in control or strategy harder and affecting how quickly shareholders can influence corporate direction.
audit committee financial
"the Board appointed Dr. Prasad as a member of the audit committee of the Board"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
compensation committee financial
"and a member of the compensation committee of the Board."
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors or Certain Officers;"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Operating Board financial
"Dr. Prasad also served on the institution’s Operating Board, Finance Committee,"
Finance Committee financial
"served on the institution’s Operating Board, Finance Committee, and as Chair"
A finance committee is a small group of board members or senior managers tasked with overseeing an organization’s financial planning, budgeting, capital allocation and reporting. Think of it as the company’s household finance team that sets spending priorities, checks financial controls and advises on big investments; its quality and decisions matter to investors because they shape cash use, risk management and the credibility of financial information investors rely on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cantor Equity Partners II, Inc. (CEPT) announce about its board?
Cantor Equity Partners II, Inc. appointed Dr. Mukesh Prasad to its board as a Class II director, effective May 8, 2026. He also joined the audit committee and the compensation committee, expanding his governance role at the company.
Who is Dr. Mukesh Prasad, the new director at Cantor Equity Partners II (CEPT)?
Dr. Mukesh Prasad is an executive and physician with experience in finance, investing, and medicine. He is Founder and Co-Managing Partner of Innova Capital Partners and an Otolaryngologist and Associate Professor at Weill Cornell Medical College, where he has practiced since 2002.
What board committees will Dr. Mukesh Prasad serve on at CEPT?
Dr. Mukesh Prasad will serve on Cantor Equity Partners II, Inc.’s audit committee and compensation committee. These assignments give him oversight roles in the company’s financial reporting processes and executive compensation decisions as part of the board’s governance structure.
How will Cantor Equity Partners II (CEPT) compensate Dr. Mukesh Prasad as a director?
Cantor Equity Partners II, Inc. approved annual compensation of $50,000 for Dr. Mukesh Prasad’s board service. This amount will be paid quarterly and reflects his role as a director, separate from his external professional positions and responsibilities.
Does Dr. Mukesh Prasad have prior links to Cantor-branded entities before joining CEPT’s board?
Yes. Dr. Mukesh Prasad has served as a director of Cantor Equity Partners V, Inc. since November 2025. That prior directorship provides familiarity with Cantor-related investment entities before his appointment to Cantor Equity Partners II, Inc.’s board.
Are there any disclosed family relationships involving Dr. Mukesh Prasad at CEPT?
The company states there are no family relationships between Dr. Mukesh Prasad and any director, executive officer, or person nominated or chosen to become an executive officer. This disclosure highlights independence from familial ties in his board appointment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
